Ruben Rizzi

Company: BioNTech AG

Job title: Senior Vice President Global Regulatory Affairs

Seminars:

Panel Discussion – A European Industry & Regulatory Perspective Into the Development & Route to Approval for Personalised mRNA Cancer Therapies 5:30 pm

Uncovering how successful mRNA cancer vaccine trials are selecting patients and achieving clinical endpoints How to reduce the personalised cancer vaccine timeline by central manufacturing and optimised logistics Navigating the regulatory frameworks for personalised medicine to ensure success post-approval  Navigating the regulatory frameworks for personalised medicine to ensure success post-approvalRead more

day: Day 1 PM